| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:818.)
© 2006 American Heart Association, Inc.
Original Contributions |
From the Department of Radiology (N.T., C.Y., B.C., T.S., H.U., J.C., M.S.F., K.R.M.), University of Washington, Seattle; Department of Cardiology (N.T.), Juntendo University School of Medicine, Tokyo, Japan; Department of Surgery (N.T., C.I., T.S.H.), University of Washington, Seattle; Mountain-Whisper-Light Statistical Consulting (N.L.P.), Seattle, Wash; Department of Neurology (G.A.G.), University of Washington, Seattle; Department of Neurology (S.C.C.), University of California, Irvine; Department of Radiology (B.H.), Virginia Mason Medical Center, Seattle, Wash; and VA Puget Sound Health Care System (T.S.H.), Seattle, Wash.
Correspondence to Thomas S. Hatsukami, MD, VA Puget Sound Health Care System, Surgery and Perioperative Care (112), 1660 S Columbian Way, Seattle, WA 98108. E-mail tomhat{at}u.washington.edu
| Abstract |
|---|
|
|
|---|
Methods A total of 154 consecutive subjects who initially had an asymptomatic 50% to 79% carotid stenosis by ultrasound with
12 months of follow-up were included in this study. Multicontrast-weighted carotid MRIs were performed at baseline, and participants were followed clinically every 3 months to identify symptoms of cerebrovascular events.
Results Over a mean follow-up period of 38.2 months, 12 carotid cerebrovascular events occurred ipsilateral to the index carotid artery. Cox regression analysis demonstrated a significant association between baseline MRI identification of the following plaque characteristics and subsequent symptoms during follow-up: presence of a thin or ruptured fibrous cap (hazard ratio, 17.0; P
0.001), intraplaque hemorrhage (hazard ratio, 5.2; P=0.005), larger mean intraplaque hemorrhage area (hazard ratio for 10 mm2 increase, 2.6; P=0.006), larger maximum %lipid-rich/necrotic core (hazard ratio for 10% increase, 1.6; P=0.004), and larger maximum wall thickness (hazard ratio for a 1-mm increase, 1.6; P=0.008).
Conclusions Among patients who initially had an asymptomatic 50% to 79% carotid stenosis, arteries with thinned or ruptured fibrous caps, intraplaque hemorrhage, larger maximum %lipid-rich/necrotic cores, and larger maximum wall thickness by MRI were associated with the occurrence of subsequent cerebrovascular events. Findings from this prospective study provide a basis for larger multicenter studies to assess the risk of plaque features for subsequent ischemic events.
Key Words: atherosclerosis carotid arteries cerebrovascular disorders magnetic resonance imaging
| Introduction |
|---|
|
|
|---|
The current challenge for MRI is to predict cerebrovascular events among asymptomatic patients with hemodynamically significant carotid stenosis using plaque composition as the determinant of vulnerability to stroke. The aim of this study was to test the hypothesis that MRI identification of specific plaque characteristics, such as the presence of intraplaque hemorrhage, a large LR/NC, or a thinned/ruptured fibrous cap, is associated with the development of subsequent ipsilateral carotid cerebrovascular events.
| Subjects and Methods |
|---|
|
|
|---|
12 months of follow-up were selected from an ongoing prospective serial carotid MRI study referred to as PRIMARI. Subjects for PRIMARI were recruited from the diagnostic vascular ultrasound laboratories at the University of Washington Medical Center, Veterans Affairs Puget Sound, and the Virginia Mason Medical Center after obtaining informed consent. The study procedures and consent forms were reviewed and approved by the institutional review board of each site. Inclusion criteria for PRIMARI include: (1) 50% to 79% carotid stenosis by duplex ultrasound; and (2) asymptomatic with regard to their carotid artery disease within the 6 months before enrollment in PRIMARI. One side was chosen for serial MRI follow-up, referred to as the index carotid artery. Exclusion criteria included: (1) previous carotid endarterectomy on the index side; (2) previous neck irradiation; and (3) contraindication for MRI.
Clinical Variables
Before the baseline MRI examination, study subjects were asked to complete a detailed health questionnaire and physical examination. The clinical end point for the study was a cerebrovascular event including stroke or transient ischemic attack (TIA) in the region supplied by the index carotid artery or ipsilateral amaurosis fugax. Only events related to the index arteries were evaluated in the present study. Follow-up continued after nonfatal events occurred. The date of symptoms of clinical end points were ascertained every 3 months by telephone interviews and confirmed through review of hospital records. Subjects who gave a history suggestive of an ischemic event were evaluated by a vascular surgeon (T.S.H.), and in suspected cases, examined by a neurologist in a timely manner. Stroke was considered to be of ischemic origin when cerebral hemorrhage was excluded by neuroimaging. TIA was defined as a new-onset focal neurological abnormality lasting <24 hours. Amaurosis fugax was defined as acute onset of transient partial or complete monocular loss of vision. Cardioemboic stroke was diagnosed according to Rochester criteria.
MRI Protocol and Review
All patients were imaged at the University of Washington in a 1.5-T GE Signa Scanner (Horizon EchoSpeed, version 5.8; General Electric Healthcare) using a phased-array surface coil (Pathway Medical Technologies Inc). A previously published standardized protocol was used to obtain 4 different contrast-weighted images (time of flight [TOF], T1-weighted [T1W], proton density-weighted [PDW], and T2-weighted [T2W]) of the carotid arteries centered at the common carotid bifurcation on the index side.12 MRI parameters were: T1W, double inversion-recovery, black-blood, 2D fast spin-echo, repetition time (TR)/effective echo time (TE)=800/10 ms, echo train length (ETL)=8; PDW and T2W, fast-spin echo, cardiac-gated, TR=3 or 4 cardiac R-R intervals, effective TE=20 ms for PDW and 40 ms for T2W, ETL=6; and 3D TOF, TR/TE 23/3.8 ms, flip angle 25°. Fat suppression was used for T1W, PDW, and T2W images to reduce signals from subcutaneous fat. Images were obtained with a field of view of 13 to 16 cm, matrix size of 256, slice thickness of 2 mm, and 2 signal averages.
Image quality was rated per artery for each contrast-weighted image on a 5-point scale (1=poor, 5=excellent) and cases in which image quality
2 were excluded from the study. Two experienced reviewers who were blinded to clinical outcome reviewed all magnetic resonance images, and a consensus decision was reached for each plaque feature.
Area measurements of the lumen, outer wall, and the tissue components (LR/NC, calcium, and hemorrhage) were obtained using a custom-designed imaging analysis tool.12 Wall area was calculated as the difference between outer wall and lumen area. The carotid bifurcation was used as a landmark for matching the 4 different contrast-weighted images at each slice location. Areas of hemorrhage, LR/NC, and calcification were identified using previously published criteria that have been validated compared with histology.12,15
Mean areas per artery were calculated for lumen, wall, intraplaque hemorrhage, LR/NC, and calcification. The mean area was defined as the sum of areas from each cross-sectional location divided by the number of cross-sectional locations analyzed. Slice-based analysis was also performed for the minimum lumen area and maximal wall thickness. The most diseased cross-sectional location, defined as the site with the maximum proportion of the wall occupied by a LR/NC (Max %LR/NC), was also calculated (%LR/NC=100x(LR/NC area/wall area). Fibrous caps status was categorized as either "thick" versus "thin or ruptured" using previously published, histologically validated criteria.11
Statistical Analysis
The association of the time to a cerebrovascular event with carotid artery characteristics as ascertained by MRI and other atherosclerotic risk factors was analyzed using the Cox proportional hazards model with the likelihood ratio test used to ascertain statistical significance. Only univariate analyses (using 1 independent variable) were performed with the Cox regression model. Meaningful multivariate analyses could not be performed because of the limited number of cases with an event. Results from Cox models are expressed as hazard ratios (HRs) with 95% CIs. The KaplanMeier product-limit method was used to estimate cumulative event-free rates in subgroups for graphical display depending on the presence of intraplaque hemorrhage and thin or ruptured fibrous cap. Data on patient and artery characteristics were expressed as mean±SD. All calculations were made with SPSS 12.0 for Windows. Statistical significance was defined as a value of P<0.05.
| Results |
|---|
|
|
|---|
2. Mean age of the 154 remaining participants was 71.1 years (range 48.4 to 87.2), and 82% were male. Mean follow-up time was 38.2 months. The baseline clinical characteristics and baseline MRI findings are presented in Table 1. A total of 111 (72%) of the subjects had arteries containing an LR/NC, and 43 (28%) had intraplaque hemorrhage into the necrotic core. Thin or ruptured caps were observed in 58 subjects (38%). During follow-up, 14 of the 154 individuals experienced an ipsilateral ischemic cerebrovascular event (4 TIAs, 6 strokes, and 4 with ipsilateral amaurosis fugax). Among the 14 cases, 2 patients with a history of intermittent atrial fibrillation had a stroke during follow-up that was felt by their neurologist and cardiologist to be cardiogenic. These 2 cases were not included as events in the analysis.
|
Among all of the baseline clinical and MRI variables listed in Table 1, Cox regression analysis indicated that plaques with intraplaque hemorrhage (HR, 5.2; 95% CI, 1.6 to 17.3; P=0.005), larger mean intraplaque hemorrhage area (HR for 10-mm2 increase, 2.6; 95% CI, 1.4 to 4.6; P=0.006), thin or ruptured fibrous cap (HR, 17.0; 95% CI, 2.2 to 132.0; P<0.001), larger maximum %LR/NC (HR for 10% increase, 1.6; 95% CI, 1.2 to 2.0; P=0.004), and maximum wall thickness (HR for a 1-mm increase, 1.6; 95% CI, 1.1 to 2.3; P=0.008) were associated with the development of subsequent ischemic cerebrovascular events (Table 2). KaplanMeier plots for the incidence of ipsilateral cerebrovascular events demonstrated that event-free survival was higher among plaques without intraplaque hemorrhage compared with those with intraplaque hemorrhage at baseline (Figure 1) and among plaques with intact, thick fibrous caps (Figure 2). Figure 3 shows a representative case of intraplaque hemorrhage with fibrous cap rupture seen on baseline MRI examination. The subject went on to develop an ipsilateral stroke 24 months later and subsequently underwent carotid endarterectomy. Histological examination of the corresponding cross-section demonstrates intraplaque hemorrhage with surface disruption.
|
|
|
|
Potential predictive factors were also analyzed within the subgroup of plaques that had an LR/NC (n=111 patients with 11 events). The presence of intraplaque hemorrhage (HR, 4.2; 95% CI, 1.1 to 16.0; P=0.022), thin or ruptured fibrous cap (HR, 8.6; 95% CI, 2.0 to 67.5; P=0.007), larger mean intraplaque hemorrhage area (HR for 10-mm2 increase, 2.3; 95% CI, 1.3 to 4.2; P=0.017), and maximum %LR/NC (HR for 10% increase, 1.5; 95% CI, 1.1 to 2.2; P=0.021) were significant predictors by Cox regression analysis.
| Discussion |
|---|
|
|
|---|
Intraplaque hemorrhage has long been recognized as a component of the complex atherosclerotic plaque. Histological studies published in the 1980s demonstrated an association between the presence of intraplaque hemorrhage and a history of TIA or stroke before carotid endarterectomy.16,17 However, the limitation of studies on excised specimens is that they are retrospective and cannot quantify the risk of future events. Several prospective ultrasound studies suggested that echolucent plaques predict an increased risk of subsequent ischemic cerebrovascular events.36 Advantages of ultrasonography include low cost and widespread availability. However, studies on the accuracy of ultrasound for identifying plaque composition have been conflicting, and ultrasound cannot reliably distinguish hemorrhage from lipid core.1820 Our study found that the presence of intraplaque hemorrhage was significantly associated with subsequent carotid cerebrovascular events. However, the presence of an LR/NC, which sometimes includes an intraplaque hemorrhage, was not significantly associated with the risk of an event. An additional analysis comparing patients with an LR/NC but without a hemorrhage (n=68) versus all other patients (n=86) showed no significant association with the risk of an event (HR, 0.4; P=0.2). These findings suggest that the ability to distinguish the LR/NC with intraplaque hemorrhage from the LR/NC without intraplaque hemorrhage may be critical.
On the other hand, analysis of the size of the LR/NC, such as the maximum %LR/NC of wall, was associated with future events. When we evaluated the association between events and the presence of a larger LR/NC, defined as greater than the mean of all plaques with a LR/NC (n=111), Cox regression univariate analysis demonstrated a significant association with subsequent ipsilateral carotid cerebrovascular events (HR, 7.0; 95% CI, 1.9 to 26.5; P=0.002).
It is well known that a thin or ruptured fibrous cap is an important morphological component of the vulnerable atherosclerotic plaque.1,2 Previous studies have shown that MRI can distinguish thick, thin, and ruptured caps with good sensitivity and specificity in vivo.11,21 In a retrospective study, Yuan et al22 demonstrated that patients with thin and ruptured fibrous caps were more likely to have had a recent TIA or stroke (odds ratio, 10 and 23, respectively) compared with plaques with thick caps identified by MRI. In line with previous histological and retrospective imaging studies, findings from our prospective study confirm the importance of fibrous cap status in the development of future ischemic complications.
The Asymptomatic Carotid Atherosclerosis Study (ACAS) evaluated the efficacy of endarterectomy in patients with a >60% diameter reduction in asymptomatic carotid stenosis.23 More recently, the largest randomized trial of endarterectomy for asymptomatic stenosis, the Medical Research Council Asymptomatic Carotid Surgery Trial (ACST), published results similar to ACAS.24,25 Both studies demonstrated absolute 5-year risk reductions with surgery of 5.3% and 5.1%, respectively. It is noteworthy that although there was a higher risk of stroke in the medically treated group, the overwhelming majority of subjects did not have an event. These findings highlight the need for developing improved criteria for identifying the characteristics of the high-risk carotid plaque, other than degree of stenosis, to better select those with asymptomatic carotid disease in need of surgical intervention.
In the present study, 2 cases were diagnosed as having a cardiogenic stroke and were not included as events in the analysis. However, even if we included those cases in the analysis, the results did not change. Cox regression analysis indicated that plaques with intraplaque hemorrhage (HR, 4.7; 95% CI, 1.6 to 14.0; P=0.004), larger mean intraplaque hemorrhage area (HR for 10-mm2 increase, 2.4; 95% CI, 1.4 to 4.1; P=0.008), thin or ruptured fibrous cap (HR, 9.4; 95% CI, 2.1 to 42.1; P<0.001), larger maximum %LR/NC (HR for 10% increase, 1.4; 95% CI, 1.1 to 1.9; P=0.01), and maximum wall thickness (HR for a 1-mm increase, 1.6; 95% CI, 1.1 to 2.1; P=0.007) were associated with the events. A limitation of this study is the small number of cerebrovascular events that occurred during follow-up in our study population. The number was too small to support a multivariate analysis. Nonetheless, highly significant associations were observed, and these findings form the basis and justification for larger, prospective studies to better define the risk of specific carotid plaque features for TIA and stroke.
In conclusion, this prospective study indicates that a thin or ruptured fibrous cap, intraplaque hemorrhage, larger maximum %lipid-rich/necrotic core, and larger maximum wall thickness as identified by MRI are significantly associated with the development of subsequent ipsilateral hemispheric TIA, stroke, or amaurosis fugax in patients with an initially asymptomatic, 50% to 79% carotid stenosis at baseline. If reproduced in larger prospective studies, MRI may provide an important tool for risk stratification and selection of candidates for invasive therapy.
| Acknowledgments |
|---|
Received September 7, 2005; revision received November 14, 2005; accepted November 28, 2005.
| References |
|---|
|
|
|---|
Related Article:
This article has been cited by other articles:
![]() |
J M U-King-Im, T Y Tang, A Patterson, M J Graves, S Howarth, Z-Y Li, R Trivedi, D Bowden, P J Kirkpatrick, M E Gaunt, et al. Characterisation of carotid atheroma in symptomatic and asymptomatic patients using high resolution MRI J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 905 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Underhill, V. L. Yarnykh, T. S. Hatsukami, J. Wang, N. Balu, C. E. Hayes, M. Oikawa, W. Yu, D. Xu, B. Chu, et al. Carotid Plaque Morphology and Composition: Initial Comparison between 1.5- and 3.0-T Magnetic Field Strengths Radiology, August 1, 2008; 248(2): 550 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Altaf, P. S. Morgan, A. Moody, S. T. MacSweeney, J. R. Gladman, and D. P. Auer Brain White Matter Hyperintensities Are Associated with Carotid Intraplaque Hemorrhage Radiology, July 1, 2008; 248(1): 202 - 209. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Kwee, R. J. van Oostenbrugge, L. Hofstra, G. J. Teule, J.M.A. van Engelshoven, W. H. Mess, and M. E. Kooi Identifying vulnerable carotid plaques by noninvasive imaging Neurology, June 10, 2008; 70(24_Part_2): 2401 - 2409. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohara, K. Toyoda, R. Otsubo, K. Nagatsuka, Y. Kubota, M. Yasaka, H. Naritomi, and K. Minematsu Eccentric Stenosis of the Carotid Artery Associated with Ipsilateral Cerebrovascular Events AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1200 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Redgrave, P. Gallagher, J. K. Lovett, and P. M. Rothwell Critical Cap Thickness and Rupture in Symptomatic Carotid Plaques: The Oxford Plaque Study Stroke, June 1, 2008; 39(6): 1722 - 1729. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshida, O. Narumi, M. Chin, K. Inoue, T. Tabuchi, K. Oda, M. Nagayama, N. Egawa, M. Hojo, Y. Goto, et al. Characterization of Carotid Atherosclerosis and Detection of Soft Plaque with Use of Black-Blood MR Imaging AJNR Am. J. Neuroradiol., May 1, 2008; 29(5): 868 - 874. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saam, H. R. Underhill, B. Chu, N. Takaya, J. Cai, N. L. Polissar, C. Yuan, and T. S. Hatsukami Prevalence of American Heart Association type VI carotid atherosclerotic lesions identified by magnetic resonance imaging for different levels of stenosis as measured by duplex ultrasound. J. Am. Coll. Cardiol., March 11, 2008; 51(10): 1014 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Yuan Carotid Atherosclerosis and Magnetic Resonance Imaging J. Am. Coll. Cardiol. Img., January 1, 2008; 1(1): 58 - 60. [Full Text] [PDF] |
||||
![]() |
T. Y Tang, S. P S Howarth, S. R Miller, M. J Graves, J.-M. U-King-Im, R. A Trivedi, Z. Y. Li, S. R Walsh, A. P Brown, P. J Kirkpatrick, et al. Comparison of the inflammatory burden of truly asymptomatic carotid atheroma with atherosclerotic plaques contralateral to symptomatic carotid stenosis: an ultra small superparamagnetic iron oxide enhanced magnetic resonance study J. Neurol. Neurosurg. Psychiatry, December 1, 2007; 78(12): 1337 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Golledge Response to Letter by Tang et al Stroke, December 1, 2007; 38(12): e158 - e159. [Full Text] [PDF] |
||||
![]() |
N. Altaf, S. T. MacSweeney, J. Gladman, and D. P Auer Response to Letters by Hsieh and Chen, and by Tang et al Stroke, December 1, 2007; 38(12): e160 - e161. [Full Text] [PDF] |
||||
![]() |
E. Mahmud, J. J. Cavendish, and A. Salami Current Treatment of Peripheral Arterial Disease: Role of Percutaneous Interventional Therapies J. Am. Coll. Cardiol., August 7, 2007; 50(6): 473 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gao, Z.-q. Chen, Y.-h. Bao, L.-q. Jiao, and F. Ling Correlation Between Carotid Intraplaque Hemorrhage and Clinical Symptoms: Systematic Review of Observational Studies Stroke, August 1, 2007; 38(8): 2382 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saam, T. S. Hatsukami, N. Takaya, B. Chu, H. Underhill, W. S. Kerwin, J. Cai, M. S. Ferguson, and C. Yuan The Vulnerable, or High-Risk, Atherosclerotic Plaque: Noninvasive MR Imaging for Characterization and Assessment Radiology, July 1, 2007; 244(1): 64 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Touze, J.-F. Toussaint, J. Coste, E. Schmitt, F. Bonneville, P. Vandermarcq, J.-Y. Gauvrit, F. Douvrin, J.-F. Meder, J.-L. Mas, et al. Reproducibility of High-Resolution MRI for the Identification and the Quantification of Carotid Atherosclerotic Plaque Components: Consequences for Prognosis Studies and Therapeutic Trials Stroke, June 1, 2007; 38(6): 1812 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Kolodgie, J. Narula, C. Yuan, A. P. Burke, A. V. Finn, and R. Virmani Elimination of Neoangiogenesis for Plaque Stabilization: Is There a Role for Local Drug Therapy? J. Am. Coll. Cardiol., May 29, 2007; 49(21): 2093 - 2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Altaf, S. T. MacSweeney, J. Gladman, and D. P. Auer Carotid Intraplaque Hemorrhage Predicts Recurrent Symptoms in Patients With High-Grade Carotid Stenosis Stroke, May 1, 2007; 38(5): 1633 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sanz, P. R. Moreno, and V. Fuster The Year in Atherothrombosis J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1740 - 1749. [Full Text] [PDF] |
||||
![]() |
P. Ijas, K. Nuotio, J. Saksi, L. Soinne, E. Saimanen, M.-L. Karjalainen-Lindsberg, O. Salonen, S. Sarna, J. Tuimala, P. T. Kovanen, et al. Microarray Analysis Reveals Overexpression of CD163 and HO-1 in Symptomatic Carotid Plaques Arterioscler. Thromb. Vasc. Biol., January 1, 2007; 27(1): 154 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Rubin Impact of Plaque Characterization on Carotid Interventions Perspectives in Vascular Surgery and Endovascular Therapy, December 1, 2006; 18(4): 312 - 315. [Abstract] [PDF] |
||||
![]() |
T. T. de Weert, M. Ouhlous, E. Meijering, P. E. Zondervan, J. M. Hendriks, M. R.H.M. van Sambeek, D. W.J. Dippel, and A. van der Lugt In Vivo Characterization and Quantification of Atherosclerotic Carotid Plaque Components With Multidetector Computed Tomography and Histopathological Correlation Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2366 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Y. Li, T. Tang, S. P.S. Howarth, and J. H. Gillard Response to Letter by Karapanayiotides and Devuyst Stroke, October 1, 2006; 37(10): 2452 - 2452. [Full Text] [PDF] |
||||
![]() |
J. R. Crouse III Thematic review series: Patient-Oriented Research. Imaging atherosclerosis: state of the art J. Lipid Res., August 1, 2006; 47(8): 1677 - 1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Moody, R. Bitar, G. Leung, and R. Maggisano Looking Beyond the Lumen Does Make All the Difference Stroke, July 1, 2006; 37(7): 1648 - 1648. [Full Text] [PDF] |
||||
![]() |
B. A. Wasserman, R. J. Wityk, H. H. Trout III, and R. Virmani Response to Letter by Karapanayiotides et al Stroke, July 1, 2006; 37(7): 1647 - 1647. [Full Text] [PDF] |
||||
![]() |
W. A. Willinek Looking Beyond the Lumen to Predict Cerebrovascular Events: "The Road Less Travelled By" Stroke, March 1, 2006; 37(3): 759 - 760. [Full Text] [PDF] |
||||
| ||||||